Compare SANM & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SANM | SNN |
|---|---|---|
| Founded | 1980 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Electrical Products | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | 12.3B |
| IPO Year | 1994 | 2002 |
| Metric | SANM | SNN |
|---|---|---|
| Price | $155.60 | $30.85 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $262.50 | $32.32 |
| AVG Volume (30 Days) | 591.4K | ★ 1.1M |
| Earning Date | 11-09-2026 | 08-04-2026 |
| Dividend Yield | N/A | ★ 2.47% |
| EPS Growth | ★ 14.07 | N/A |
| EPS | ★ 4.71 | N/A |
| Revenue | ★ $7,890,475,000.00 | N/A |
| Revenue This Year | $74.08 | $4.89 |
| Revenue Next Year | $18.06 | $5.25 |
| P/E Ratio | ★ $32.82 | $64.97 |
| Revenue Growth | ★ 16.78 | N/A |
| 52 Week Low | $118.10 | $26.30 |
| 52 Week High | $288.68 | $37.09 |
| Indicator | SANM | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 28.15 | 76.57 |
| Support Level | $138.52 | $29.18 |
| Resistance Level | $164.83 | $31.36 |
| Average True Range (ATR) | 10.07 | 0.47 |
| MACD | -6.56 | 0.43 |
| Stochastic Oscillator | 7.19 | 92.53 |
Sanmina Corp is a provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers in the communications networks, storage, industrial, defense, and aerospace end markets. The operations are managed as two businesses: Integrated Manufacturing Solutions, which consists of printed circuit board assembly and represents a majority of the firm's revenue; and Components, Products, and Services, which includes interconnect systems and mechanical systems. The firm generates revenue mainly in the United States, China, and Mexico, but has a presence around the world.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.